Fibroadenoma risk factors: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
Mahshid |
||
Line 45: | Line 45: | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] |
Revision as of 23:25, 26 November 2017
Fibroadenoma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Fibroadenoma risk factors On the Web |
American Roentgen Ray Society Images of Fibroadenoma risk factors |
Risk calculators and risk factors for Fibroadenoma risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Haytham Allaham, M.D. [2]
Overview
Common risk factors in the development of fibroadenoma are obesity, eostrogen replacement therapy, and nulliparity.[1][2]
Risk Factors
Risk Factor | Description |
---|---|
Obesity | An increase in BMI is correlated with an increased risk of fibroadenoma development. |
Estrogen replacement therapy | Estrogen replacement therapy is correlated with an increased risk of fibroadenoma development. |
Pregnancy | Nulliparous women are associated with an increased risk of fibroadenoma development. Whereas multiparous women are associated with a lower risk of fibroadenoma development. |
Contraception | The use of oral contraceptive pills is associated with a lower risk of fibroadenoma development as compared to other contraceptive methods. |
Socioeconomic status | A higher socioeconomic status is correlated with an increased risk of fibroadenoma development. |
References
- ↑ 1.0 1.1 Greenberg R, Skornick Y, Kaplan O (1998). "Management of breast fibroadenomas". J Gen Intern Med. 13 (9): 640–5. PMC 1497021. PMID 9754521.
- ↑ 2.0 2.1 Fibroadenoma. Wikipedia (2015) https://en.wikipedia.org/wiki/Fibroadenoma Accessed on January, 29 2016